LAG3 and neoplasm: Prior studies have shown a high percentage of T cells in tumor-infiltrating lymphocytes (TILs) in ESCC tumors, and LAG-3 expression may be high on CD8 + TIL from ESCC, playing an important role in regulating CD8 TIL function alongside PD-1.